A Multi Centre Study to Determine the Feasibility of Using an Integrated Consent Model to Compare Standard of Care Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Chemotherapy-Induced Febrile Neutropenia in Early Stage Breast Cancer (React-G Study)
Clinical trial NCT02428114 · COMPLETED
Trial details
- NCT number
- NCT02428114
- Sponsor
- Ottawa Hospital Research Institute
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-05-01
- Primary completion
- 2017-03-01
- Enrollment
- 142
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.